Portfolio Manager Factsheet
Xencor was higher as investor enthusiasm over the company’s late stage pipeline increased materially. Biogen traded lower after a company spokesperson said they were enrolling additional patients in the company’s high-profile, late stage, Alzheimer’s disease trial.
Worldwide Healthcare Trust PLC conducts its affairs so that its shares can be recommended by independent financial advisers (IFAs) to retail private investors. The shares are excluded from the Financial Conduct Authority's (FCA's) restrictions which apply to non-mainstream investment products because they are shares in a UK-listed investment trust.